BACKGROUND Aberrant activation of phosphorylated form of glycogen synthase kinase-3β[pS9GSK-3β(Serine 9 phosphorylation)] is known to trigger Wnt/β-catenin s
AIM To investigate the potential benefit of combining the cMET inhibitor crizotinib and cisplatin we performed in vitro combination studies.METHODS We tested th